ZIMV News and Press, ZimVie Inc. From 09/26/23

WESTMINSTER, Colo., Sept. 26, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that on September 7, 2023, the U.S. Food and Drug Administration approved its Mobi-C ® Cervical Disc Hybrid Investigational De...

2023-08-17 12:25:55 ET More on ZimVie ZimVie Inc. 2023 Q2 - Results - Earnings Call Presentation ZimVie Inc. ( ZIMV ) Q2 2023 Earnings Call Transcript ZimVie: Downgrade To A Hold On Valuation And Fundamentals ZimVie gains on FDA nod for new Mobi-C cervical ...

ZimVie and Brainlab will cooperate on achieving compatibility between ZimVie’s Vital™ and Virage ® fixation systems with the Brainlab spine and trauma technologies for global co-marketing purposes WESTMINSTER, Colo., Aug. 17, 2023 (GLOBE NEWSWIRE) -- ZimVie ...

2023-08-10 08:50:25 ET More on ZimVie ZimVie Inc. 2023 Q2 - Results - Earnings Call Presentation ZimVie Inc. ( ZIMV ) Q2 2023 Earnings Call Transcript ZimVie: Downgrade To A Hold On Valuation And Fundamentals ZimVie adds 15% most in four months on favorab...

WESTMINSTER, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that on August 1 st , 2023, the U.S. Food and Drug Administration approved a smaller height of the Mobi-C ® Cervical Disc i...

2023-08-06 02:21:01 ET ZimVie Inc. (ZIMV) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Vafa Jamali - President and Chief Executive Officer Rich Heppenstall - Chief Financial...

2023-08-02 23:00:36 ET Image source: The Motley Fool. ZimVie (NASDAQ: ZIMV) Q2 2023 Earnings Call Aug 02, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: ZimVie (ZIMV) Q2 2023 Earnings Call Transcript

2023-08-02 17:19:44 ET ZimVie press release ( NASDAQ: ZIMV ): Q2 Non-GAAP EPS of $0.17 beats by $0.14 . Revenue of $224.9M (-4.1% Y/Y) beats by $12.9M . For further details see: ZimVie Non-GAAP EPS of $0.17 beats by $0.14, revenue of $224.9M beats by $12.9M

Third Party Net Sales of $224.9 million Net Loss of ($23.4) million; Net Loss Margin of (10.4%); Adjusted Net Income [1] of $4.3 million Diluted EPS of ($0.89); Adjusted Diluted EPS [1] of $0.17 Adjusted EBITDA [1] of $29.7 million; Ad...

2023-07-17 09:53:11 ET ZimVie ( NASDAQ: ZIMV ) soared 11% amid a report that the maker of dental implants and spinal devices is working with a bank in respond to inbound takeover interest. It's not clear which bank is advising ZimVIe ( ZIMV ), according to a Dealreport...